Optical coherence tomography in Alzheimer's disease: A meta-analysis

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Coppola, Gianluca ^a   Di Renzo, Antonio ^a   Ziccardi, Lucia ^a   Martelli, Francesco ^b   Fadda, Antonello ^b   Manni, Gianluca ^c   Barboni, Piero ^d   Pierelli, Francesco ^e,f   Sadun, Alfredo A ^g   Parisi, Vincenzo ^a  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f IRCCS NEUROMED   (Italy)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; HUMAN; IMAGE ANALYSIS; MACULAR THICKNESS; META ANALYSIS; MILD COGNITIVE IMPAIRMENT; OPTICAL COHERENCE TOMOGRAPHY; RETINAL NERVE FIBER LAYER THICKNESS; AGED; DEMOGRAPHY; PATHOLOGY; PROCEDURES; PUBLISHING; RETINA;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DEMOGRAPHY; HUMANS; PUBLICATION BIAS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84941955657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134750     Document Type: Article

References (64)

1. Blennow K, Leon MJD, Zetterberg H (2006) Alzheimer's disease. The Lancet 368:387-403.
2. Waring S, Rosenberg R (2008) Genome-wide association studies in Alzheimer disease. Arch Neurol. 65:329-334. doi: 10.1001/archneur.65.3.329 PMID: 18332245
3. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH et al. (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 58:397-405. PMID: 11255443
4. Roberts R, Knopman D (2013) Classification and epidemiology of MCI. Clin Geriatr Med. 29:753-772. doi: 10.1016/j.cger.2013.07.003 PMID: 24094295
5. Gainotti G, Quaranta D, Vita M, Marra C (2014) Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis. 38:481-495. doi: 10.3233/JAD-130881 PMID: 24002185
6. Hutton J, Morris J, Elias J, Poston J (1993) Contrast sensitivity dysfunction in Alzheimer's disease. Neurology. 43:2328-2330. PMID: 8232951
7. Gilmore G, Whitehouse P (1995) Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis. Optom Vis Sci. 72:83-91. PMID: 7753532
8. Crow R, Levin L, La Bree L, Rubin R, Feldon S (2003) Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer's dementia. Invest Ophthalmol Vis Sci. 44:875-878. PMID: 12556424
9. Gilmore G, Wenk H, Naylor L, Koss E (1994) Motion perception and Alzheimer's disease. J Gerontol. 49:P52-P57. PMID: 8126359
10. Rizzo M, Nawrot M (1998) Perception of movement and shape in Alzheimer's disease. Brain.: 2259-2270. PMID: 9874479
11. Wijk H, Berg S, Sivik L, Steen B (1999) Colour discrimination, colour naming and colour preferences among individuals with Alzheimer's disease. Int J Geriatr Psychiatry. 14:1000-1005. PMID: 10607966
12. Wijk H, Berg S, Bergman B, Hanson A, Sivik L, Steen B (2002) Colour perception among the very elderly related to visual and cognitive function. Scand J Caring Sci. 16:91-102. PMID: 11985755
13. Salamone G, Di Lorenzo C, Mosti S, Lupo F, Cravello L, Palmer K et al. (2009) Color discrimination performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 27:501-507. doi: 10. 1159/000218366 PMID: 19451717
14. Cogan D (1985) Visual disturbances with focal progressive dementing disease. Am J Ophthalmol. 100:68-72. PMID: 3893141
15. Whitehouse P, Price D, Clark A, Coyle J, De Long M (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol. 10:122-126. PMID: 7283399
16. Van De Nes J, Nafe R, Schlote W (2008) Non-tau based neuronal degeneration in Alzheimer's disease - an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. Brain Res. 1213:152-165. doi: 10.1016/j.brainres.2008.03.043 PMID: 18455153
17. Leuba G, Kraftsik R (1994) Visual cortex in Alzheimer's disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks. Neurobiol Aging. 15:29-43. PMID: 8159261
18. Armstrong R (2005) Is there a spatial association between senile plaques and neurofibrillary tangles in Alzheimer's disease? Folia Neuropathol. 43:133-138. PMID: 16245206
19. Sadun A, Borchert M, De Vita E, Hinton D, Bassi C (1987) Assessment of visual impairment in patients with Alzheimer's disease. Am J Ophthalmol. 104:113-120. PMID: 3618708
20. Hinton D, Sadun A, Blanks J, Miller C (1986) Optic-nerve degeneration in Alzheimer's disease. N Engl J Med. 315:485-487. PMID: 3736630
21. Sadun A, Bassi C (1990) Optic nerve damage in Alzheimer's disease. Ophthalmology. 97:9-17. PMID: 2314849
22. Löffler K, Edward D, Tso M (1995) Immunoreactivity against tau, amyloid precursor protein, and betaamyloid in the human retina. Invest Ophthalmol Vis Sci. 36:24-31. PMID: 7822152
23. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W et al. (1991) Optical coherence tomography. Science. 254:1178-1181. PMID: 1957169
24. Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS et al. (1995) Imaging of macular diseases with optical coherence tomography. Ophthalmology. 102:217-229. PMID: 7862410
25. Schuman JS, Hee MR, Puliafito CA, Wong C, Pedut-Kloizman T, Lin CP et al. (1995) Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 113:586-596. PMID: 7748128
26. Parisi V, Manni G, Gandolfi SA, Centofanti M, Colacino G, Bucci MG (1999) Visual function correlates with nerve fiber layer thickness in eyes affected by ocular hypertension. Invest Ophthalmol Vis Sci 40:1828-1833. PMID: 10393056
27. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S et al. (1999) Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 40:2520-2527. PMID: 10509645
28. Parisi V, Manni G, Centofanti M, Gandolfi SA, Olzi D, Bucci MG (2001) Correlation between optical coherence tomography, pattern electroretinogram, and visual evoked potentials in open-angle glaucoma patients. Ophthalmology 108:905-912. PMID: 11320021
29. Parisi V, Pierelli F, Coppola G, Restuccia R, Ferrazzoli D, Scassa C et al. (2007) Reduction of optic nerve fiber layer thickness in CADASIL. Eur J Neurol 14:627-631. PMID: 17539939
30. Kardon R (2011) Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol. 31:353-361. PMID: 22089499
31. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol. 112:1860-1867. PMID: 11595144
32. Parisi V (2003) Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease. Semin Ophthalmol. 18:50-57. PMID: 14566623
33. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J (2007) Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett. 420:97-99. PMID: 17543991
34. Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R et al. (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci Lett. 480:69-72. doi: 10.1016/j.neulet.2010.06.006 PMID: 20609426
35. Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol. 33:58-61. PMID: 22918296
36. Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C et al. (2013) Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 54:5953-5958. doi: 10.1167/iovs.13-12046 PMID: 23920375
37. Kesler A, Vakhapova V, Korczyn A, Naftaliev E, Neudorfer M (2011) Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg. 113:523-526. doi: 10. 1016/j.clineuro.2011.02.014 PMID: 21454010
38. Mahmoudian M, Ebrahimi S, Kiani Z (2009) An image processing technique for diagnosis of Alzheimer's disease. J Res Med Sci. 14:205-209. PMID: 21772885
39. Tian T, Zhang B, Jia Y, Li Z (2014) Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease. Dis Markers. 2014:826503. doi: 10.1155/2014/826503 PMID: 24688166
40. Shen Y, Shi Z, Jia R, Zhu Y, Cheng Y, Feng W et al. (2013) The attenuation of retinal nerve fiber layer thickness and cognitive deterioration. Front Cell Neurosci. 7:142. doi: 10.3389/fncel.2013.00142 PMID: 24065883
41. Shen Y, Liu L, Cheng Y, Feng W, Shi Z, Zhu Y et al. (2014) Retinal nerve fiber layer thickness is associated with episodic memory deficit in mild cognitive impairment patients. Curr Alzheimer Res. 11:259-266. PMID: 24484274
42. Shi Z, Wu Y, Wang M, Cao J, Feng W, Cheng Y et al. (2014) Greater attenuation of retinal nerve fiber layer thickness in Alzheimer's disease patients. J Alzheimers Dis. 40:277-283. doi: 10.3233/JAD-131898 PMID: 24413621
43. Kromer R, Serbecic N, Hausner L, Froelich L, Aboul-Enein F, Beutelspacher SC (2014) Detection of Retinal Nerve Fiber Layer Defects in Alzheimer's Disease Using SD-OCT. Front Psychiatry. 5:22. doi: 10.3389/fpsyt.2014.00022 PMID: 24616709
44. Ascaso F, Cruz N, Modrego P, Lopez-Anton R, Santabárbara J, Pascual LF et al. (2014) Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. J Neurol. 261:1522-1530. doi: 10.1007/s00415-014-7374-z PMID: 24846203
45. Yu J, Feng Y, Xiang Y, Huang J, Savini G, Parisi V et al. (2014) Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One. 9:10.
46. Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis JP et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 6:10.
47. Higgins J, Thompson S, Deeks J, Altman D (2003) Measuring inconsistency in meta-analyses. BMJ. 327:557-560. PMID: 12958120
48. Egger M, Davey S, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629-634. PMID: 9310563
49. Larrosa JM, Garcia-Martin E, Bambo MP, Pinilla J, Polo V, Otin S et al. (2014) Potential new diagnostic tool for Alzheimer's disease using a linear discriminant function for Fourier domain optical coherence tomography. Invest Ophthalmol Vis Sci. 55:3043-3051. doi: 10.1167/iovs.13-13629 PMID: 24736054
50. Blanks J, Torigoe Y, Hinton D, Blanks R (1996) Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging. 17:377-384. PMID: 8725899
51. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17:385-395. PMID: 8725900
52. Ning A, Cui J, To E, Ashe K, Matsubara J (2008) Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci. 49:5136-5143. doi: 10.1167/iovs.08-1849 PMID: 18566467
53. Perez S, Lumayag S, Kovacs B, Mufson E, Xu S (2009) Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. Invest Ophthalmol Vis Sci. 50:793-800. doi: 10.1167/iovs.08-2384 PMID: 18791173
54. Koronyo-Hamaoui M, Koronyo Y, Ljubimov A, Miller CA, Ko MK, Black KL et al. (2011) Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 1:S204-S217.
55. Liu B, Rasool S, Yang Z, Glabe CG, Schreiber SS, Ge J et al. (2009) Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. Am J Pathol. 175:2099-2110. doi: 10.2353/ajpath.2009.090159 PMID: 19834067
56. Schon C, Hoffmann NA, Ochs SM, Burgold S, Filser S, Steinbach S et al. (2012) Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS One. 7:10.
57. Cohen RM, Rezai-Zadeh K, Weitz TM, Rentsendorj A, Gate D, Spivak I et al. (2013) A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss. J Neurosci. 33:6245-6256. doi: 10.1523/JNEUROSCI.3672-12.2013 PMID: 23575824
58. Tsai CS, Ritch R, Schwartz B, Lee SS, Miller NR, Chi T et al. (1991) Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch Ophthalmol. 109:199-204. PMID: 1993028
59. Hedges TR 3rd, Perez Galves R, Speigelman D, Barbas NR, Peli E, Yardley CJ (1996) Retinal nerve fiber layer abnormalities in Alzheimer's disease. Acta Ophthalmol Scand. 74:271-275. PMID: 8828725
60. Iseri P, Altina O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol. 26:18-24. PMID: 16518161
61. Moreno-Ramos T, Benito-Leon J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. J Alzheimers Dis. 34:659-664. doi: 10.3233/JAD-121975 PMID: 23271313
62. Kromer R, Serbecic N, Hausner L, Froelich L, Beutelspacher S (2013) Comparison of visual evoked potentials and retinal nerve fiber layer thickness in Alzheimer's disease. Front Neurol. 4:203. doi: 10. 3389/fneur.2013.00203 PMID: 24379800
63. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO et al. (2004) Mild cognitive impairment.beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 256:240-246. PMID: 15324367
64. Berisha F, Feke G, Trempe C, McMeel J, Schepens C (2007) Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 48:2285-2289. PMID: 17460292